Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsPension (IS)Preferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShort-Term Debt repayments
Ratios

Bruker (BRKRP) EBIAT (2016 - 2025)

Bruker's EBIAT history spans 16 years, with the latest figure at $26.3 million for Q4 2025.

  • For Q4 2025, EBIAT rose 91.97% year-over-year to $26.3 million; the TTM value through Dec 2025 reached -$7.8 million, down 106.83%, while the annual FY2025 figure was -$8.3 million, 107.34% down from the prior year.
  • EBIAT reached $26.3 million in Q4 2025 per BRKRP's latest filing, up from -$58.5 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $204.6 million in Q4 2023 to a low of -$58.5 million in Q3 2025.
  • Average EBIAT over 5 years is $55.4 million, with a median of $56.9 million recorded in 2021.
  • Peak YoY movement for EBIAT: surged 440.0% in 2021, then crashed 243.03% in 2025.
  • A 5-year view of EBIAT shows it stood at $75.7 million in 2021, then grew by 28.67% to $97.4 million in 2022, then skyrocketed by 110.06% to $204.6 million in 2023, then crashed by 93.3% to $13.7 million in 2024, then skyrocketed by 91.97% to $26.3 million in 2025.
  • Per Business Quant, the three most recent readings for BRKRP's EBIAT are $26.3 million (Q4 2025), -$58.5 million (Q3 2025), and $7.6 million (Q2 2025).